$2.40
+0.17 (+7.62%)
Open$2.21
Previous Close$2.23
Day High$2.50
Day Low$2.21
52W High$58.73
52W Low$20.32
Volume—
Avg Volume364.5K
Market Cap11.83M
P/E Ratio51.42
EPS$0.76
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+1,721.7% upside
Current
$2.40
$2.40
Target
$43.72
$43.72
$35.70
$43.72 avg
$58.20
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.18M | 3.97M | 4.44M |
| Net Income | -1,151,363 | -1,086,006 | -951,664 |
| Profit Margin | -27.6% | -27.4% | -21.4% |
| EBITDA | -1,394,086 | -1,159,340 | -1,348,527 |
| Free Cash Flow | -921,744 | -1,324,564 | -1,179,947 |
| Rev Growth | +11.5% | +10.2% | +12.2% |
| Debt/Equity | 0.72 | 0.66 | 0.63 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |